Post-earnings recap
Reported
Wed, Jul 24, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Thermo Fisher Scientific reported better-than-expected earnings per share, but the stock fell by 1.79% following the results. Investors may have been looking for more detailed revenue figures or guidance, which were not provided. The slight earnings beat suggests the company is managing to perform well in a competitive environment, but the stock reaction indicates some caution among investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.04 | N/A | +0.54% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in their strategic direction. They emphasized the importance of maintaining growth despite market challenges.
Management highlighted strong demand in key segments.
They noted ongoing investments in innovation and capacity expansion.